Myriad Genetics (NASDAQ: MYGN) soars 36.94% on news it will sell its Prenatal Health testing business to Labcorp for $210 ...

Arcus Biosciences (NYSE:RCUS) makes the NYSE top gainer list, up 9.53% on new ARC-20 data for casdatifan in clear cell renal cell carcinoma.

Nigel Green of deVere Group says a Democratic sweep of Congress on 3 November would reshuffle US stock market sectors, ...

Paul Rejczak on the S&P 500's rebound from Friday's low, earnings from NFLX and SPCX, and the months-long consolidation that ...

Anna Radomska on the dollar's invalidated weekly breakout and copper testing the lower line of a rising wedge, with the key ...